Add BrightSurf on Google Email

New study reveals immune system changes linked to schizophrenia and treatment resistance

Researchers found significant differences in immune cell populations between healthy individuals and people with schizophrenia, with the CD4/CD8 ratio emerging as a potential biomarker for predicting treatment response. Lower levels of mucosal-associated invariant T cells may signify immune dysregulation in schizophrenia.

SourceAgency for Science, Technology and Research (A*STAR), Singapore·JournalBrain Behavior and Immunity·TypeExperimental study·DateJan 15, 2025

Neuron special issue explores the science of aging

The Neuron special issue sheds light on the science of aging, focusing on how age-related changes impact the brain's ability to clear waste and transport energy. The collection also explores the link between the immune system and brain health.

SourceCell Press·JournalNeuron·TypeLiterature review·DateJan 8, 2025

Your immune cells are what they eat

Researchers at Salk Institute establish a novel framework for the relationship between nutrition and cell identity. They found that a nutritional switch from acetate to citrate plays a key role in determining T cell fates, shifting them from active effector cells to exhausted cells.

SourceSalk Institute·JournalScience·DateDec 12, 2024

“Missing link” between brain and body inflammatory signals identified in the skull

A study from King's College London reveals that the dural sinuses and skull bone marrow act as a likely interface between the central and peripheral immune systems, suggesting a potential link between brain and body inflammatory signals. The research highlights areas of the skull that work as 'traffic lights' between the two systems.

SourceKing's College London·JournalBrain·TypeImaging analysis·DateDec 9, 2024

Opioids interfere with cancer immunotherapy but these drugs could help

New research from the University of Pittsburgh found that opioids can suppress the immune system and reduce the effectiveness of immunotherapy for head and neck cancer. However, peripherally restricted OPRM1 antagonists (PAMORAs) may block opioid-induced immunosuppression and improve response rates to immune checkpoint inhibitor therapy.

SourceUniversity of Pittsburgh·JournalJournal for ImmunoTherapy of Cancer·DateDec 5, 2024

Infertility linked to onset of systemic autoimmune rheumatic disease after childbirth

Women with infertility are at higher risk of developing SARD, including lupus and Sjögren's syndrome, even after accounting for pre-eclampsia and other pregnancy complications. Infertility treatments do not appear to increase this risk, suggesting that women may be undiagnosed or untreated.

SourceEuropean Society of Human Reproduction and Embryology·JournalHuman Reproduction·TypeObservational study·DateDec 4, 2024

Fine particulate air pollution may play a role in adverse birth outcomes

A new study finds that fine particulate air pollution (PM2.5) exposure is associated with altered immune responses and increased inflammation in pregnant women, leading to adverse birth outcomes. The study highlights the importance of minimizing air pollution exposure in pregnant women to protect maternal and fetal health.

SourceHarvard T.H. Chan School of Public Health·JournalScience Advances·TypeExperimental study·DateNov 29, 2024

How fungi colonize plant roots

Researchers have deciphered how the beneficial fungus Serendipita indica successfully colonizes plant roots of Arabidopsis thaliana. The fungus secretes enzymes that produce a molecule called deoxyadenosine (dAdo), which activates cell death in plants, enabling colonization without causing significant harm.

SourceUniversity of Cologne·JournalCell Host & Microbe·TypeExperimental study·DateNov 27, 2024

New tool reveals how malaria sticks to red blood vessels

A new gene-editing tool enables precise study of variable proteins that allow malaria parasites to stick to red blood cells and evade the immune system. The study introduces a platform to explore how malaria causes disease and identifies new proteins involved in the cytoadhesion process.

SourceeLife·JournaleLife·DateNov 26, 2024

Promise in fighting drug-resistant pathogens innovative study shows

A new study developed an innovative approach to combat antibiotic-resistant bacteria by tagging them with a chimeric agent that activates the immune system towards them. This tagging technique helps the immune system recognize and eliminate elusive pathogens, offering a promising new direction for fighting drug-resistant infections.

SourceThe Hebrew University of Jerusalem·JournalBioconjugate Chemistry·TypeExperimental study·DateNov 14, 2024

A new technology to isolate immunostimulatory members of the human gut microbiota: next-generation IgA-seq

Scientists at UMC Utrecht developed a new technology to isolate and study gut bacteria recognized by IgA antibodies, which are associated with various diseases. The next-generation IgA-SEQ method allows for high-throughput identification and analysis of these immunostimulatory bacteria, shedding light on their role in health and disease.

SourceUniversity Medical Center Utrecht·JournalMicrobiome·TypeExperimental study·DateNov 14, 2024

Air pollution exposure may be associated with eczema

A new study published in PLOS ONE suggests that air pollution exposure may be associated with an increased risk of eczema. Data from hundreds of thousands of U.S. adults found that every 10-µm/m3 increase in PM2.5 levels doubles the eczema rate among residents.

SourcePLOS·JournalPLOS ONE·TypeObservational study·DateNov 13, 2024

Wyss Institute’s iNodes team receives ARPA-H Sprint for Women’s Health award to advance the first implantable immune organs to treat ovarian cancer

The Wyss Institute's iNodes team has been awarded an ARPA-H Sprint for Women's Health to develop implantable immune organs for treating ovarian cancer. The iNodes concept is based on the formation of lymphoid organs in tumors, which can be reprogrammed to attack cancer cells and retain a long-term immune memory.

New antibody could be promising cancer treatment

Researchers at Uppsala University have developed a unique antibody that targets and delivers a drug package while activating the immune system. This '3-in-1 design' method has shown promise in treating several types of cancer by amplifying T cell effect on cancer tumors.

SourceUppsala University·JournalNature Communications·TypeExperimental study·DateNov 11, 2024

'Black box' of stem cell transplants opened in world-first blood study

Researchers tracked the long-term dynamics of transplanted stem cells in patients' bodies up to three decades post-transplant. They found that younger donors produce more vital stem cells, while older donors experience reduced immunity and higher relapse risk. The study provides new insights into donor selection and transplant success.

SourceWellcome Trust Sanger Institute·JournalNature·TypeObservational study·DateOct 30, 2024

Researchers at Tel Aviv University discovered a cancer mechanism that can eliminate tumors – even those resistant to immunotherapy

Researchers at Tel Aviv University have discovered a new cancer mechanism that prevents the immune system from attacking tumors. The discovery was made by reversing this mechanism, which stimulates the immune system to fight cancer cells, including those resistant to prevailing forms of immunotherapy.

SourceTel-Aviv University·JournalNature Communications·DateOct 30, 2024

Algae research provides insight on immune health

A new study by University of Texas at Arlington researchers found that living with symbiotic algae weakens the immune system of jellyfish, making them more vulnerable to infections. This finding has important implications for coral reef conservation and human disease prevention.

SourceUniversity of Texas at Arlington·JournalProceedings of the Royal Society B Biological Sciences·TypeExperimental study·DateOct 30, 2024

Terasaki Institute researchers develop promising nanoparticle-based approach to obesity treatment

Researchers at Terasaki Institute have developed simvastatin-loaded nanoparticles to target adipose tissue inflammation, promoting fat tissue browning and weight loss. The treatment effectively inhibits obesity-related inflammation, controlled white fat production, and demonstrated strong anti-inflammatory effects.

SourceTerasaki Institute for Biomedical Innovation·JournalACS Nano·TypeExperimental study·DateOct 28, 2024

Three experts explain how research is being done to make immunotherapy effective in an increasing number of breast cancers

Immunotherapy holds promise for treating breast cancer, but its effectiveness varies. Researchers Karin de Visser, Sandra Demaria, and María Casanova-Acebes discuss advances and challenges in applying immunotherapy to this common tumor. They highlight the importance of factors like diet, biorhythms, and personalized approaches to impro...